Physician profile
Timothy E Fee
NPI 1003876251
$5,600.17
in general payments reported to CMS, 2019-2025
20 companies · $1,156 in 2025
The $1,156 reported for 2025 was more than what a typical Plastic and Reconstructive Surgery provider received nationally (typical 2025 total: $445).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,336 · 2020: $298 · 2021: $1,039 · 2022: $633 · 2023: $572 · 2024: $565 · 2025: $1,156.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,293.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,293.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $1,201.37 | 2019-2022 | |
| Merz North America, INC. | $1,083.79 | 2019-2022 | |
| Mentor Worldwide LLC | $871.17 | 2019-2025 | Mentor Memorygel Resterilizable Gel Sizer, Artoura Breast Tissue Expander |
| Motiva USA, LLC | $581.05 | 2024-2025 | |
| Tela Bio, INC. | $381.69 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Allergan, INC. | $340.53 | 2019-2022 | |
| Abbvie INC. | $319.54 | 2023-2025 | |
| Biotissue Holdings INC. | $142.81 | 2022-2023 | |
| Musculoskeletal Transplant Foundation INC. | $120.00 | 2024 | |
| Depuy Synthes Sales INC. | $111.83 | 2019-2025 | Matrixrib, Matrixmandible, Matrixorthognathic |
| Galderma Laboratories, L.P. | $106.01 | 2019-2025 | |
| Next Science LLC | $103.01 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $56.00 | 2019-2024 | Exparel |
| Acell, INC. | $51.12 | 2019 | |
| Solventum Corporation | $46.73 | 2024-2025 | Activ.A.C., Promogran Prisma, Prevena |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $20.63 | 2020 | |
| Integra Lifesciences Corporation | $19.72 | 2021 | |
| Davol INC. | $18.67 | 2019 | |
| Sanara Medtech INC. | $12.95 | 2023 | Celleraterx |
| Smith+Nephew, INC. | $11.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Timothy Fee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.